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ABSTRACT 
The presence of POMC peptides in PML was investigated using immunocyto-
chemis try. Virtually all PML obtained from cow, pig, dog, and rat donors 
stained positively for immunoreactive ACTH (ir-ACTH). Bovine PML also 
stained positively for ir-met-enkephalin and porcine PML for ir-~­
endorphin . 
The release of ir-ACTH by bovine PML was investigated by radioimmuno-
assay (RIA) . The assay characteristics were determined. The RIA 
sensitivity was observed to be 11.1 ± 1.8 pg/ ml ACTH (x ± SEM, n=ll ), ye t 
the release of ir-ACTH from bovine PML was not detected under basal or 
stimulated conditions. 
After characteriz ing the presence of POMC peptides in PML, a potential 
role was hypothesized. The ability of POMC peptides to modulate the 
function s and activities of immune cells has been observed. A summary of 
POMC peptide effects on immune cells has been included in the General 
Discussion. 
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GENERAL INTRODUCTION 
The immune system is composed of many different ce l l types. For 
example, the lymphocytes that function in acquired immunity are not 
constrained to a specific tissue; however, they are found to be 
concentrated in secondary lymphoid organs: the lymph nodes and the spleen 
(Mota, 1986) . The lymphocytes, like all immune cells, are carefully 
regulated to control the nature an d magnitude of their response to foreign 
material. Two types of regulatory signalling are observed to occur in the 
control of a immune response (Janeway et al., 1985). 
The f i rst type of regulatory signal l ing involves direct cell-to-cell 
contact. For interaction to take p l ace, membrane receptors of one cell 
recognize and bind the ligands on another cell. No interaction will take 
place if the receptor a nd ligand are not complementary in structure: 'lock 
and key' recognition. This type of signalling occurs at many stages of an 
immune response (Unanue and Al len, 1987). 
The second type of regulatory signalling is mediated by s oluble 
peptides. After stimulat ion, some immune cel l s release soluble peptides, 
cytokines, into the extracellular fluid. These cytokines then modulate the 
activities of a ny cell possessing the necessary receptors. For example, 
inte r leukin 1 ( IL-1) is released by activated macrophages and functions 
with antigen presentation to initiate helper T-lymphocyte differentiation 
and maturation (Widman, 1989). 
Macrophages are not unique in t his respect, lymphocytes have also been 
observed to release cytokines. The cytokines released by immune cells are 
a heterogenous group of peptides. For example, considerable evidence 
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suggests that the proopiomelanocortin (POMC) peptides may function as 
potential cytokines. These peptide hormones are more traditionally 
associated with the anterior pituitary (the most important POMC peptides 
are ACTH, ~-endorphin, and met-enkephalin); however, the synthesis of POMC 
peptides by macrophages and lymphocytes has been reported (Smith and 
Blalock, 1981; Lolait et al., 1984; Bost et al., 1987; Buzzetti et al., 
1989). 
In addition to local production by immune cells, POMC peptides have been 
implicated in regulating the nature and magnitude of a immune response. 
For example, adrenocorticotropic hormone (ACTH) has been reported to 
suppress the production of antibodies by B lymphocytes (Johnson et al., 
1982), and to block the activation of peritoneal macrophages by a-
interferon (Koff and Dunegan, 1985). ~-endorphin has been observed t o 
enhance the proliferative response of rat spleenic lymphocytes to T-
lymphocyte mitogens (Gilman et al., 1982) and, ~-endorphin and met-
enkephalin have been observed to enhance the cytotoxic activities of 
natural killer cells (Mathews et al., 1983; Faith et al., 1984; Froelich 
and Bankhurst, 1984; Kay et al., 1984; and Mandler et al., 1986). Clearly , 
POMC peptides can modulate the activities of an immune response within the 
body. To strengthen the view that POMC peptides act as cytokines, it is, 
of course, necessary to establish that POMC peptides are stored and 
released by PML . Assessment of the immunoactivity of POMC peptides is not 
sufficient evidence to assign POMC peptides to the PML-derived- cytokine 
category . Hence, further information on the synthesis and release of POMC 
peptides by PML was required to determine the peptides role in controlling 
3 
a developing immune response. 
Accordingly, PML of humans and mice have been reported to store 
immunoreactive a dre nocort i cotropic hormone ( ir-ACTH ) and related POMC 
p e ptides (Lolait et al., 1985; Harbour - McMenamin et al., 1985; Smith et 
al., 1985 ; Bost et al., 1987; Meyer et a l. , 1987). However, these data 
were derived from only two different mammalian species . To gain fur ther 
support for the hypothesis that POMC peptides released from mammalian PML 
serve a general function in controlling an immune response , it was 
necessary to show the synthesis and release of POMC peptides from PML of 
other mammalian species. The pu rpose of t h e current study was to further 
charac terize the synthesis a nd release of POMC peptides from a broad 
spectrum of mammalian spec i es. To accomplish this goal , the current study 
was divided into two separate and complementary sections. 
In the first series of experiments, the storage of ir-ACTH and related 
POMC peptides by PML of cows, pigs , dogs, a nd rats was i nvestigated using 
immunocytochemistr y ( ICC ). ICC is a technique that utilizes the 
specificity of t h e antibody/antigen interaction to identify the presence or 
absence of an an tigen in a tissue section or cell preparation. This 
a nt igen can be structural, cytoplasmi c, or nuclear i n nature. 
After it was successfully demonstrated that PML stored ir-POMC peptides 
(e.g. , ACTH, ~ - endorphin , and met-enkeph a lin), a second series of 
e xpe riments was performed to detect t he release of ir-ACTH from PML. To 
study the r elease of ir-ACTH, bovine PML were cultured at several different 
concentrations a nd then subjected to a variety of t reatments. The media 
obtained from the c ultures of bovine PML was quantitated for ir-ACTH 
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content by radioimmunoassay (RIA). 
The secretagogues that stimul ate the release of ir-ACTH from bovine PML 
were not known, therefore, the bovine PML were treated with two 
pharmacological agents: (1) A23187, a calcium ionophore that increases 
cytoplasmic calcium ion concentrations in treated cell types, and (2) 
phorbol-12-myristate - 13-acetate (PMA) , a phorbol ester that activates 
protein Kinase C in treated cell types. These a r e both major signalling 
pathways associated with cell secretion . Bovine PML were also treated with 
Concanavalin A (ConA) and corticotropin releasing factor (CRF), both of 
which have been reported to stimulate increases in ir-ACTH content of human 
and mouse PML (Besedovsky et al., 1981; Harbour-McMenamin et al., 1985; 
Smith et a l., 1986; Kavelaar s et a l ., 1989). 
The results of these two complementary studies served to characterize 
the ability of mammalian PML to synthesize, store, and release POMC 
peptides. The current studies were designed to establish if POMC peptides 
might function as potential cytokines. After characterizing the presence 
of POMC peptides in mammalian PML, it was possible to speculate on the 
function of POMC peptides in immunoregulation. 
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SECTION I. THE SYNTHESIS OF ADRENOCORTICOTROPIC HORMONE ( ACTH) AND 
RELATED PROOPIOMELANOCORTIN ( POMC) PEPTIDES BY PERIPHERAL 
MONONUCLEAR LEUKOCYTES ( PML) 
Introduct ion and Lite r a t u r e Revi ew 
ACTH is a polypeptide, thirty - nine amino acids in length, produced 
primar ily in the a n ter ior pituitary gland. I t is relate d to a large family 
of peptides through t h e precursor , POMC p r otein. As seen in Figure 1.1, 
the POMC protein is p r ocessed in the a n terior lobe of the pituitary to 
produce ACTH, a - melanocyte stimul ating hormon e (a -MSH), and ~-lipotropin 
(~-LPH). Further processing of these POMC products occurs in the 
intermediate lobe of the pituitary to yield ~-MSH, corticotropin-like 
peptide (CLIP ) , ~ - LPH , and ~-endorphin. 
ACTH has been noted to exert a wide range of effects on a variety of 
immune cell types. The i n vitro production of antibodies by mouse spleen B 
lymphocytes is suppressed by the administration of ACTH to the cultures 
(Johnson et al., 1982). ACTH has also been ascribed a role in the release 
of cytokines by mouse spleenocytes: administration of ACTH to spleenocyte 
c ulture s suppresses the production of ~-interferon- a cytokine involved in 
anti-viral responses (Johnson et al., 1984). Finally, ACTH has been 
observed to block the induction of mouse peritoneal macrophages to the 
tumoricidal state by ~-interferon (Koff and Dunegan , 1985). 
In contrast to the suppressor functions associated wi th ACTH, ~­
endorphin has been observed to enhance the proliferative res p onse of rat 
s pleenic lymphocytes to the T lymphocyte mitogens Concanavalin A and 
Figure 1.1: Processing of the proopiomelanocortin ( POMC ) molecule in the 
anterior and intermediate lobes of the pituitary gland. The 
precursor POMC protein contains the sequence for 1-melanocyte 
stimulating hormone (1-MSH). In the anterior lobe POMC is 
processed to produce adrenocorticotropic hormone (ACTH, amino 
acids 1-39 ), and ~-lipotropin (~ -LPH, 1-91). These two 
peptides are further processed in the intermediate lobe. 
ACTH is cleaved to yield o-MSH (1-13) and corticotropin- like 
peptide (CLIP, 18-39) while ~-LPH is cleaved to yield 1-LPH 
( 1-58) and ~ -endorphin (61 -91). The first six amino acids of 
~ -endorphin contain the sequence for met-enkephalin (61 - 66). 
(Modified from S. Reichlin: In: Wi l liams Te x t book of 
Endocrinolgy , 7th ed., JD Williams and DW Foster, eds., 
Saunders, Philadelphia, 1985, p. 502) 
signal N-terminal fragment 
peptide 
y-MSH 
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ACTH P-LPH 
Anterior Lobe ~ 
- ACTH (1-39) P-LPH (1-91) 
Intermediate I 
lobe l 
CI-MSH CLIP y-LPH 
(1-13) (1 8-39) (1-58) P-endorpnin 
(61 -91 ) 
~ 
met enkepha1in 
(61-66) 
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phytohemagglutinin (Gilman et al., 1982). ~-endorphin and met-enkephelin 
have been shown to enhance the cytotoxic activities of natural killer cells 
(Mathews et al. , 1983; Faith et al., 1984; Froelich and Bankhurst, 1984 ; 
Kay et al., 1984; and Mandler et al. ,1986). 
It is possible that the effects of ACTH and ~-endorphin are 
complementary in action and act to enhance one capac i ty of the immune 
response while s uppres sing another. In order to better understand the role 
' 
of the POMC related peptides in the developing immune response, it is 
necessary to determine if the peptides a re produced locally at the site of 
stimulation or at some other site. 
If the POMC peptides a re produced elsewhere, then the amount of peptide 
needed to affect an immune response is greatly increased. The peptide must 
enter the circulatory system and circulate t hrough the body before 
interacting with the cells involved in acquired immunity. In addition , a n 
efficient f e edback mechanism would be required to achi eve the level of 
control exhibited by the immune system during antigeni c stimulation. 
To circumvent this situation, it is possible that ACTH, ~-endorphin, and 
other POMC peptides are produced locally by the immune cells themselves. 
Several lines of evidence support t h e hypothesis that PML synthesize and 
release POMC related peptides. 
The expression of the POMC gene has been demonstrated in PML of several 
mammalian species. Human PML express the gene for POMC as demonstrated by 
the specific binding of a labelled DNA probe to a Northern blot of the mRNA 
(Buzzetti et al . , 1989 ) . Bovine PML activated with bovine herpesvirus-1 in 
vitro have been observed to express the gene for POMC. The mRNA of the 
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activated bovine PML was observed to contain a seque nce which was bound by 
a s pecific labelled human DNA probe for the POMC message (Westly and 
Splitter, 1987 ) . Activated mouse T-helper cells h ave also been observed to 
produce mRNA for preproenkephalin (Zurawski et al., 1986). Given that 
immune cells expressed the gene for POMC related peptides, it was predicted 
t hat POMC proteins would a l s o be synthesized by the immune cells. 
Several different approaches were used to study t he synthesis of POMC 
peptides by PML . The first method involved the staining of tissue sections 
or cell preparations by immunocytochemistry ( I CC). Cells that have bee n 
positively stained by ICC procedures are termed immunoreactive ( ir). 
Immunoreactive p - e ndorphin has been identified in mous e s pleen macrophages 
( Lolai t et al., 1984) by indirect immunofluorescence ICC. 
If the tissue section or cell preparation failed to stain positively for 
the peptide of interest, it was poss ible to increase the a mount of stored 
peptide by pre-exposing the cells to mitogenic stimul i. Human PML have 
been s hown to be capable of producing p-endorphin a nd ACTH following a wide 
variety of treatments. In par t icular, human PML produce ir-p-endorphin and 
ir-ACTH a ft e r: ( 1) in vitro infection with Newcastle's disease viru s 
(Smith et a l. , 1982); (2) in vitro stimulation with the endotoxin 
lipopolysaccharide ( Harbour -McMena min et a l. , 1985); (3) in vitr o 
stimulation with co r ticotropin releas ing factor (Smith et a l. , 1986); and 
(4) in vivo administration of a typhoid vaccine (Meyer et al., 1987) . 
A second alternative for detecting p e ptides produced in small quantities 
was u t ilize d in t h e current s tudy. Instead of increasing protein stores 
with mi togenic stimuli , the s ignal amplification of the technique was 
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improved. Several variations of ICC methodology have been devised that 
increase the degree of signal amplifi cation; however, before discussing 
improvements to the ICC, it is first necessary to understand the principles 
of the technique . 
ICC is a technique that enables one to detect the presence or absence of 
a specific antigen in a tissue or cell preparation. The detection of the 
antigen is based on the primary ant ibody raised against the molecule of 
interest. A primary antibody attaches to any molecule in the cell which 
contains the antigenic determinants recognized by the primary antibody . 
Several different methodologies may be used to locate cells which bind the 
primary a ntibody. These methods can be divided into two basic groups: 
direct and indirect labelling of the primary antibody. 
The s implest is the direct method. In this case the primary antibody i s 
labelled directly. The label conjugated to the primary antibody can be 
radioactive (e .g., I 125 labelled immunoglobulin), e nzymatic (e . g., 
peroxidase conjugated to t he immunoglobulin), or fluorescent (e.g., 
isothiocyana te conjugated to t he immunoglobulin). 
The direct method is the least sensitive in detecting cellular peptides. 
A single peptide antigen is labelled by only the primary antibody. If the 
peptide is s mall, t hen, at most, several primary antibodies can bind to it . 
A three to four fo ld amplification of the signal is probably the best that 
can be achieved by direct ICC. 
The purpose of indirect methodology is to increase the amplification of 
the signal. I n the indirect method, a second molecule that attaches 
specifically to the primary antibody is labe lled. Once again there are 
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several methods of labelling this molecule. In general, the second 
molecule is an antibody that has been raise d against the primary antib__ody. 
For example, if the primary antibody is isolated from a rabbit inoculated 
with the antigen of interest, then the secondary antibody will be an anti-
rabbit - immunoglobulin antibody . 
In the indirect ICC methodology the sensitivity is greatly increased. 
Consider a simple case where three primary antibodies can bind the peptide; 
furthermore, ass~e that four labelled secondary a ntibodies can bind a 
single primary antibody . In this situation, the signal has been amplified 
twelve fold; a significant improvement in resolution over the direct 
method. 
Even greater amplification can be obtained by the indirect avidin-
biotinylated-peroxidase complex (ABC) method, the most sensitive of ICC 
methodologies. In brief, a tissue section or cell preparation is incubated 
first with a primary antibody raised against the molecule of interest. 
Next, a biotinylated secondary antibody that recognizes the primary 
antibody is incubated with the tissue section or cell preparation. The 
antigen -primary -secondary -antibody complex is then localized by adding the 
ABC reagent to the tissue section or cel l preparation. 
The ABC reagent is formed by incubating a suspension of avidin, a 
protein containing four high affinity binding sites for biotin with 
biotinylated horseradish peroxidase. During the incubation, many large 
complexes of avidin and biotinylated peroxidase are formed. Upon adding 
the ABC reagent to the tissue section or cell preparation, the unoccupied 
avidin domains remaining on individual ABC complexes are bound to the 
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biotinylated secondary antibodies. 
The antigen labelled by the primary-secondary-antibody-ABC is resolved 
by incubating the cell preparation in a solution containing an electron 
donor like 3,3'-diaminobenzidene (DAB). The reducing agent is locally 
oxidized by the peroxidase enzyme in a ABC to form an amorphous precipitate 
at the site of antigen binding. The precipitate is visible on the tissue 
sections or cell preparations when examined under a light microscope. 
In the ABC method there are multiple points where t h e signal is 
amplified . Besides the initial amplification of the signal by twelve due 
the binding of the primary and secondary antibodies, asswne that the 
biotinylated secondary antibodies are bound by two of ABC complexes. 
Furthermore, although the ABC complex has not been characterized , asswne 
that four peroxidase enzymes a re bound in a single complex. Thus, t he 
s i gnal is amplified at least 96 t imes and probably more by the ABC method. 
Clearly the degree of signal amplification achieved by the ABC methodology 
is greater than that achieved by simple indirect methods . 
It should be recognized , however, that all ICC methodology has some 
limitations . While it is possible to determi ne if the cel l / tissue in 
question stores a molecule that can interact with the primary antibody, it 
is not possible to determine with exact nature of the reacting antigen or 
when the antigen first appears in the cell. Moreover, ICC provides no 
proof of actual hormone release, although it is commonly assumed that 
positively staining cells also release product. 
The second method for studying the cytoplasmic constituents of cells is 
gel electrophoresis. The gel matrix separates a mixture of proteins on the 
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basis of size. As the protein mixture moves through the gel matr ix , the 
migration of the larger proteins through the gel is impeded more than that 
smaller proteins. Thus , proteins of similar gel mobility concentrate into 
discrete bands as the protein mixture moves through the gel. These protein 
bands can be further characterized by a technique known as Western 
blotting. 
In Western blotting, t h e proteins in the gel are transferred (blotted) 
onto a nitrocellulose or nylon memb r ane. The membrane is then screened fo r 
the protein of interest with a n antibody raised against the protein. To 
determine where the antibody has bound on the blot, the antibody can be 
labelled either directly or indirectly (see above). The positions of the 
labelled proteins are determined by radioautography or chromogens. 
The Western blot provides more information about a cellular protein than 
ICC. Not only does Western blotting enable a researcher to assess the 
ability of a cell preparation to synthesis a protein, it also provides an 
estimate of protein size and of the quantities produced in the cell. 
In summary, the above investigations indicate that cells of the immune 
system are capable of the local production of ACTH and ~-endorphin. The 
following series of experiments were performed to further characterize the 
synthesis of POMC proteins by PML. The primary question addressed was this: 
do PML of species other than humans and mice store POMC peptides? 
Mate rials and Methods 
Animals: Blood of the donor animal was collected into a syringe 
containing Sml of an Acid Citrate Dextrose (ACD) solution for each 4Sml of 
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whole blood collected . AGO was made by dissolving 132g sodium citrate, 58g 
citric acid, and lSOg dextrose into three liters of reagent grade water. 
For each experiment, a fresh supply of blood was utilized. The methods of 
collection were as follows : 
Rat: Each experiment required approximately 30ml of fresh rat blood. 
Each Harlem Sprague-Dawley rat provided about 5 to 6ml of whole blood. A 
rat was placed into a large jar containing a wad of cotton soaked with 
diethyl ether. As soon as the rat lost consciousness , it was removed from 
the jar and placed under a fume hood . Anesthesia was maintained with a 
funnel that had its neck stuffed with cotton that was then drenched with 
diethyl ether. 
With a syringe containing the AGO solution ready, the skin of the 
abdomen was peeled back to e xpose the underlying abdominal muscles . The 
abdominal c avity was opened with a mid-line incision using a pair of 
scissors. Next, the intestines were moved to the one side to expose the 
kidneys -sometimes it was necessary to remove the adipose tissue to expose 
the kidney s. Rostral to the kidney , and running parallel to the spinal 
column was the large dorsal aorta. The needle of the syringe (18-20 gauge) 
was inserted into the artery and the blood slowly withdrawn. The procedure 
was repeated on additional rats until at least 30ml of fresh rat blood was 
obtained. 
Canine: Each experiment required approximately 200ml of fresh canine 
blood. Each greyhound provided SOml of blood a nd four donors were used in 
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a single experiment . 
While one person restrained the dog , its head was tilted back and 
slightly to one side to expose the jugular vein . Fourty-five ml of whole 
blood was collected by venepunct ure into a SOml syringe containing Sml of 
ACD. The syringe was then inverted several times before the procedure was 
repeated on anothe r greyhound. 
Bovine: The blood used in the bovine experiments was provided by Dr. 
Roth 's group in t h e Dep a rtment of Veteri nary Microbiology and Preventative 
Medicine. The wh ole blood was collected by venepuncture into a 250ml 
sterile screw top bottle containing 25ml ACD on the morning of the 
experiment. 
Porcine: The blood used in the porcine experiments was kindly provided 
by two sources: the ISU Meat Laboratory and Dr. Roth's research group. 
The whole blood was co l lected by venepuncture on the morning of the 
experiment. As before, the sample contained Sml of ACD per 45ml of whole 
blood . 
Leukocyte preparation : The isolation procedure for the mononuclear 
peripheral leukocytes was the same for each species. Whole blood 
containing Sml ACD/ 45ml whole blood was divided into an even number of SOml 
plas t ic centrifuge tubes and spun on the Centra - 8 centrifuge (Inter national 
Equipment Compa ny) at 850g for 22 minutes. After centrifugation , the 
sample s were placed in a laminar flow hood. The huffy coat , the top of the 
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plasma/ cell interface, was drawn off along with Sml of plasma and placed 
into a lSml plastic centrifugation tube . To each lSml centrifugation tube 
was added Sml of a density gradient (Sepracell-MN, Sepratech Corporation) . 
After adding the Sepracell-MN, each tube was capped, inverted several times 
and spun on the Centra-8 centrifuge at 1900g for 22 minutes. 
Following centrifugation with the Sepracell-MN density gradient, a 
distinct white band of mononuclear leukocytes was apparent just below the 
meniscus in each centrifuge tube. The white band was collected from each 
tube with a sterile Pasteur pipet and combined into a single lSml 
centrifuge tube which was then filled to capacity with Hank's Balanced Salt 
Solution (G ibco). The sample was triturated with a sterile Pasteur pipet , 
and spun on a Clinical centrifuge (International Equipment Company) at 
setting 6 for five minutes. Next, the supernatant was decanted from the 
tube and Sml of Hank's medium was added back before the pellet was 
triturated with a sterile Pasteur pipet and filtered through a sterile 25µm 
mesh into a fresh lSml centrifugation tube. The filtrate was then diluted 
to lOml with fresh Hank's medium, the tube inverted several times, and an 
aliquot was taken for a cell count on a hemocytometer. 
The sample was then spun on the Clinical centrifuge at setting 6 for 5 
minutes; t he supernatant was discarded and the pellet was diluted with 
Hank's Balanced Salt Solution to at a concentration of 2 x 106 cells per ml 
of solution. The cells thus obtained were a mixture of mononuclear 
leukocytes . Approximately 5% of the preparation were monocytes and the 
rest was a mixture of T lymphocytes and B lymphocytes ( information provided 
by the Sepratech Corporation). 
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Mur i ne pituitary preparat ion : The anterior lobe of the pituitary was 
isolated from a freshly killed Harlem Sprague-Dawley rat and placed into a 
sterile s iliconized petri dish (6cm diameter ) containing 2ml of Spinner's-
0.1% bovine serum albumin (BSA) which was made by adding l.lml penicillin-
streptomycin (Gibco) and 2 . 6ml 4% BSA to lOOml of Spinner's Minimal 
Essential Medium (Gibco) . The petri dish was placed i n a laminar flow hood 
where the anterior lobe was transferred to a larger sterile, siliconized 
petri dish (lOcm diameter), rinsed several times with fresh Spinner ' s-0 . 1% 
BSA , and cut into approximately l mm3 pieces with sterile scalpel blades. 
The pieces were next transferred to a siliconized spinner's flask 
containing lOml of a lmg/ml trypsin solution in Spinner's-0.1% BSA that was 
filtered through a Millex-GV filter. The flask was gassed through a 
sidear m for 20 seconds with 5% C02/ 95% air, placed in a 37°C water bath 
and left to incubate with stirring for 50 minutes. After stirring, the 
suspension was triturated under a laminar flow hood using a sterile pipet , 
gassed again with 5% C02/ 95% air, and pl aced in a 37°C water bath to 
incubate for an additional 30 minutes . This procedure was repeated at 20 
minute intervals thereafter until the pituitary pieces were no longer 
visible. 
After dispersing the pituitary cells, they were transferred to a 15ml 
centrifugat ion tube, made up to 15ml with Spinner's and spun on a Clinical 
centrifuge (IEC) at setting 5 for 10 minutes. The supernatant fluid was 
decanted , 5ml Spinner's was added to pellet which was then triturated with 
a Pasteur pipet. An aliquot was removed for a cell count on a 
hemocytometer, then the suspension was made to lSml with Spinner's and spun 
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on a Clinical centrifuge at setting 5 for 10 minutes. 
The pellet was resuspended in enough DMEM-0.1% BSA (lOOml Dulbecco's 
Modified Eagles Medi um, Gibco; l.lml penicillin streptomycin (10,000 
units/ml), Gib co; 2.6ml 4% BSA) to achieve a concentration of 2 to 4 x 106 
cells per ml of medium and transferred to a sterile plastic petri dish. 
The cells were placed in a humidified incubator (Queue Cell Culture 
Incubator, Queue Systems , Inc.) at 37°C, 5% C02/ 95% air, for 3 hours 
before the DMEM solution was decanted and replaced with 2ml of DMEM-10% 
horse serum (lOOml DMEM, Gibco; l . lml penicillin streptomycin, Gibco; 
ll.3ml horse serum, Gibco). The pituitary cells were then incubated 
overnight in a humidified Queue incubator at 37°C, 5% C02 / 95% air. 
Prior to staining, the pituitary cells were retrypsinized from the 
plastic petri dish as follows. The DMEM-10% horse serum was poured off and 
replaced by 2ml of a trypsin solution (2 . Smg trypsin, lOml Spinner' s-0 .1% 
BSA). The bottom of the dish was tapped lightly after 5 minutes. The 
solution was transferred with rinsing into a 15ml centrifuge tube after 10 
minutes. The centrifuge tube was made to 15ml with Spinner ' s and spun on a 
Clinical centrifuge at setting 5 for 10 minutes. The super natant fluid was 
decanted, the pellet resuspended in 5ml of Spinner's and an aliquot was 
removed for a cell count on a hemocytometer. The suspension was then made 
to lSml with Spinner's and spun for an additional 10 minutes. The 
supernatant was again decanted and the cells were suspended in sufficient 
DMEM - 0.1% BSA to achieve a concentration of 2 x 106 cells per ml of medium. 
Leukocyte immunoc y t ochemistr y: One hundred µl of peripheral mononuclear 
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leukocytes ( PML) at a concentration of 2 x 106 cells per ml of Hank's 
medium were placed inside a hydrophobic ring that had been inscribed at one 
end of a poly- 1 - lysine coated microscope slide using a PAP Pen ( Daido 
Sangyo Co., LTD.). The slides were then placed inside ICC trays and 
transferred to a Queue incubator at 37°C, 5% C02/ 95% air, for 30 minutes 
to allow attachment of the PML to the s lides . After thirty minutes, the 
slides were gently washed three times wi t h Tris buffer that was made up as 
follows. 6.06g Trizma base and 8.77g NaCl were dissolved in one liter of 
doubled distilled water ; the resulting solution was adjusted to a pH of 
7.6 with l.OM HCl . 
After rinsing with t he Tris buffer, t h e slides were submerged in ice 
cold ethanol at 4°C for 10 minutes to fix the cells on the s lides. The 
slides were t hen washed three times wi t h Tr i s and drie d outside the PAP 
ring with light s uction. A solution of hydrogen peroxide (lml 30% hydrogen 
peroxide , lOml double distilled water) was then placed i nside the PAP rings 
for f i ve minutes . Hydrogen peroxide treatment of PML destroyed endogenous 
peroxidase act i vi ty. 
The slides were then rinsed with Tris and suction dried outside the PAP 
ring. Next, diluted normal goat serum (180µ1 normal goat serum, Vectastain 
ABC Kit, Vector; 9.82ml Tri s) was placed inside t he PAP rings containing 
the PML for thirty minutes . Normal goat serum was added to prevent non-
specific binding of the ant ibodies to the PML. 
After thirty minutes the normal goat se rum was r emoved with light 
suction , and replaced with t h e primary antibody (anti -human ACTH 
immunoglobulin, rabbit raised, Dako Corporation). The slides were 
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i ncubated wi th the pr imary antibody fo r ninety minutes in humidi fied ICC 
trays. The primary antibody was prepared in dilutions of 1:100 to 1:2000 
(v:v) by diluting the stock antibody solution (as obtained from Dako) with 
Tris. This antibody was obtained from whole serum. 
At the end of ninety mi nutes, the slides were washed three times with 
Tris and then dried wi th suction before the biotinylated secondary antibody 
(biotinylated anti-rabbit goat immuno-globulin , ABC Kit) was added to the 
interior of the PAP rings . The secondary antibody was allowed to incubate 
on the slides for thirty minutes before the slides were washed off by three 
Tris rinsings and then s uction dried . 
The inside of the PAP rings were next flooded with a preformed solution 
of the avidin-biotinylated-peroxidase complex (ABC Kit, Vector) and allowed 
to incubate for forty-five minutes. The avidin-biotinylated-peroxidase 
complex (ABC) was formed incubating 90µ1 of 'A ' and 90µ1 of ' B' (reagents 
supplied in the Vectastain ABC KIT, Vector) together in 9 . 88ml of Tris 
buffer for at least twenty minutes. 'A' contained a suspension of avidin, 
a protein with four high affinity binding sites for biotin. 'B ' contained 
a suspension of a multi-biotinylated horseradish peroxidase enzyme. After 
incubating together for twenty minutes, a number of l arge complexes, the 
ABC reagent, were formed that contained multiple copies of the peroxidase 
enzyme. 
The slides were then washed three times with Tris, placed into slide 
holders, and developed for 5 minutes in the peroxi dase developing solution. 
This solution was formed by combining lSOml of a filtered Tris Solution 
containing lmg/ml 3,3 ' -diaminobenzidene (DAB) and lSOml of a 5% nickel 
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s ulfate solution containing 200µ1 30% hy drogen peroxide. DAB was oxidized 
by t he bound ABC complex to form an a morphous precipitate at the site of 
t h e r eaction. This nickel e nhanced precipitate was v isible under a light 
microscope. 
Finally, the slides were rinsed three times in distille d water , rinsed 
for 5 minutes in tap wa ter, and dehydrated in the following ethanol series 
f or one minute each: 50% EtOH , 70% EtOH, 80% EtOH , 95% EtOH, 100% EtOH , 
50% EtOH/ 50% x y l en e, 100% xylene. After dehydrating t h e sl i des, 
coversl ips were mounted o n the slides with Quick-Mount (Daido Sanygo Co . , 
LTD.). 
In each experiment , a set of duplicate s lides was run fo r each 
treatment . A series of con trols were run to reduce the possibili ty of non~ 
spec ific staining. These con trols included t h e following: ( 1) omission of 
the primar y a ntibody, (2) omission of t h e seconda r y a n tibody, (3) omission 
of the primary and secondary antibodies, (4) a ddition of normal rabbit 
serum instead of primary ant ibody at same d i lut i on as pr i mary antibody , (5) 
a serial di lution o f the primary a n tibody, and (6) preabsorption of the 
primary a ntibody wi th 50ng/ ml ACTH for 90 minutes at room temperature. In 
addition , red blood ce lls wer e s ubjected to the same staining procedure to 
serve as a negati ve contro l . 
Each experiment was replicated t hree times or more. 
Pituitary immunocytochemistry : The anterior pituitary gland was 
isolated a nd s ubjected to staining to serve as a posi t i ve control. It has 
been reported that 5- 10% of the cells in t h e anterio r p ituitary p r oduce 
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ACTH (Childs et al., 1989) and thus, a similar percentage of the dispersed 
pituitary cells were expected to stain positivel y for ir-ACTH in this 
laboratory. 
The procedure followed for staining the pituitary cells was the same as 
the immunocytochemistry of the leukocytes, as described in detail above, 
except for fixation of the cells. 100µ1 of the retrypsinized pituitary 
cells at a concentration of 2 x 106 cells per ml of DMEM-0.1% BSA were 
placed inside the PAP ring inscribed at one end of a poly-1-lysine coated 
microscope slide. The slides were placed in humidified ICC trays and 
transferred to a Queue incubator at 37°C, 5% C02/ 95% air for 45 minutes. 
After incubating for 45 minutes, the slides were rinsed three times with 
Tris and then suction dried outside the PAP rings. The slides were then 
c overed with a 9:1 B-5 fixative ( 68g/l mercuric chloride, 13.61 g/ l sodium 
acetate ) to formaldehyde solution for 10 minutes. After ten minute s , the 
slides were bathed in 95% ethanol for one minute and then in double-
distille d water for one minute. The slides were then subjected to t he 
following series of 1 minute baths: Lugol's Iodine ( 10.15 g/ l iodine , 
19.92 g/l sodium iodide ); doubled-distilled water; sodium thiosulfate , 
19.85 g/l; and Tris. 
Following the last bath in Tris, the slides were suction dried outside 
the PAP rings and covered with a solution of saponin (0.5mg/ ml) for thirty 
minutes. Next, the slides were rinsed three times with Tris, suction dried 
outside the PAP ring and then c overed with a hydrogen peroxide solution . 
The procedure after this point was the s ame as described above for 
leukocyte ICC. 
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Western blot: The western blot was performed on t he l ysate of bovine 
PML to confirm the synthesis of ir-ACTH. After the final spin in the 
leukocyte i so l ation procedure (see above) and before bovine PML are 
resuspended , 2ml of lysis buffer (l.25ml NP40; 250µ1 of 10 ,000 KIU/ml 
transylol; lml 0.5M Hepes- pH 7.25; dilute to 25ml with double distilled 
water) was added to the pel l et in the centrifugation tube. The mixture was 
next vortexed for several minutes and then spun on a Clinical centrifuge at 
setting 6 for 10 minutes. The supernatant fluid obtained from the lysate 
was decanted from the centrifuge tube and then respun on the Clinical 
centrifuge for an additional 10 minutes at setting 6. This supernatant 
fluid was either loaded on a polyacrylamide gel or frozen in 50µ1 aliquots 
at - 20°C for later use. 
In addition to the supernatant l ysates, I 125 -ACTH, ACTH, and cytochrome 
c were loaded into separate wells of the polyacrylamide gel. I 125 -ACTH was 
loaded to serve as a v isible marker of ACTH migration in the gel; it did 
not require labelling by the antibody to be detected by radioautography. 
ACTH was loaded on the gel to serve as a positive control for the 
resolution of the blot. If the unlabelled ACTH was not visible in the 
radioautograph of the blot, t hen the antigen labelling procedure had 
failed . 
marker; 
Cytochrome c was loaded on the gel to serve as a molecular weight 
it had a known mass of 10.5 kDa. 
Pouring the Gel: The 15% polyacrylamide gel was poured just b efore the 
protein sampl e was loaded . After constructing the mould for the ge l and 
sealing the edges with 1% agarose , 15ml of degassed 15% acrylamide solution 
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was mixed with 7.5µ1 of N,N,N ' ,N '- tetramethy lethy lenediamine (TEMED) and 
10µ1 of 10% ammonium persulfate and quickly transferred to the mould with a 
Pasteur pipet . The ge l was cove r ed with an overlay solution and allowed to 
polymerize for thirty minutes . The overlay solution was prepared by mixing 
20ml of Tris buffer ( 181. 5g/l Trizma adjusted to a pH of 8 . 9), l ml of 1% 
SDS, a nd 79ml of dis t illed water. 
Running the Gel : After the gel had polymerized, the overlay solution 
was poured off and t he stacker added. The stacker was made from a 5ml of 
degassed 5% acrylamide solution mixed with 2.5µ1 of TEMED and 50µ1 of 1 0% 
ammonium persulfate and then transferred to the top of the gel with a 
Pasteur p ipet. After the stacker solution was adde d to the top of the 15% 
polyacrylamide gel, a comb was inserted to form the lanes for running the 
protein. 
The comb was r emoved from the ge l a fter t hirty minutes, and the 
resulting wells were rinsed wi th d i st illed water and dried wi th a needle 
attached to a vacuum. The gel was then inverted, t h e bottom s p acer of the 
mould r emoved, a nd the space was filled with 1% agarose-SDS. Once the 
spacer had set, the gel was sealed on to t h e polyacrylamide gel 
electr oph oresis ( PAGE) apparatus with 1% agarose-SDS. 
The PAGE apparatus reservoirs were f ille d with running buffer ( 172 . 8g 
g l ycine ; 36g Trizma base; 6g SDS; diluted to six liters with distilled 
water) after each lane of the gel had been loaded with the appropriate 
protein samp l e or s t andard. Each well was loaded with either 30µ1 of 
solution con taining a 1:1 mixture of sample to 2x SOS loading buffer (25ml 
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5 . 7% Tris solution- pH 6.9, 20ml glycerol, 8ml 0.1% bromphenol blue, 43ml 
distilled water, 4g SOS, and 200µ1 ~-mercaptoethanol/5ml of buffer) or lx 
SOS loading buffer (5ml 2x SOS loading buffer diluted to lOml with 
distilled water). Some samples were heat treated (l00°C, 2 minutes) before 
being loaded in the wells. 
A power supply was then attached to the PAGE apparatus and the gel was 
allowed to run until the bromphenol blue indicator entered the bottom 
spacer. The power was then turned off and the gel was blotted. 
Blotting the Gel: The resolved gel was soaked for thirty minutes in 
degassed transfe r buffer ( 1 6.3g Trizma base; 1.21 methanol; 54g glycine; 
diluted to 6 liters with double distilled water). The soaked gel was then 
placed in a sandwich made with the transfer cassette (Transfor a pparatus, 
Hoefer Scientific Instruments). The sandwich consisted of: (1) a Dacron 
sponge on t h e first half of t he cassette, (2) two sheets of Whatman 3mm 
filter paper, (3) a nitrocellulose membrane cut to the size of the gel and 
presoaked in the transfer buffer, (4) the resolved gel soaked in transfer 
buffer, (5) two additional pieces of 3mm Whatman filter paper, and (6) the 
second half of the cassette. The cassette was t hen placed in the Trans for 
apparatus, four liters of the degassed transfer buffer were added, and a 
power supply was connected with the anode on the nitrocellulose side of the 
cassette. 
The voltage was adjusted to lOOV at the beginning of the transfer, and 
the current was kept below 0.9 mA. The electrotransfer was continued for 
three hours before the cassette was disassembled and the blot resolved. 
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Resolving the Blot and Gel: The blot was resolved using radiolabelled 
1 125 Protein A as follows . The nitrocellulose membrane was incubated with 
a 1:200 solution of normal rabbit serum for thirty minutes at room 
temperature with mild shaking. Next, the rabbit serum was poured off and 
membrane was incubated with 1 : 100 solution of anti-human ACTH 
immunoglobulin (Dako Corporation) for two hours at room temperature with 
mild shaking. The membrane was then rinsed three times with Tris for ten 
minutes each time. After rinsing, the membrane was soaked in a solution 
containing 5 x 105 cpm of 1125 Protein A in 2% nonfat powdered milk 
(dissolved in doubled distilled water) for 2.5 hours with gentle shaking. 
Following the Protein A incubation, the membrane was rinsed three times 
with Tris for 10 minutes each time. 
To facilitate localization of the standards, the membrane was stained in 
Ponceau C reagent and the position of the unlabelled standards were marked 
with radioactive lead. The membrane was then wrapped in plastic wrap, and 
exposed at -70°C to a pre-flashed Kodak X-ray film for 10 days. 
After blotting the polyacrylamide gel, it was stained in Coomassie Blue, 
impregnated with 2,5-diphenyloxazole (PPO) by soaking it in a 20% PPO 
dimethyl sulfoxide solution, placed on a piece of filter paper cut to the 
size of the gel, dried on a gel dehydrator , and then wrapped in plastic 
wrap. Finally, the ge l was exposed to a pre-flashed Kodak X-ray film at 
-70°C for 10 days . 
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Resu lts 
I mmunocytochemis try validation : ICC was performed on the peripheral 
mononuclear leukocytes (PML) derived from the followin g mammalian species: 
rat, bovine, porcine, and canine. Each mammalian species was probed for 
the synthesis of adrenocorticotropic hormone (ACTH). In addition, the 
synthesis of other p r oopiomelanocortin (POMC) peptides by PML was examined 
in bovine and porcine species. The bovine PML were tested for the 
synthesis of met - enkephalin and the porcine PML were tested for ~-endorphin 
synthesis. 
A series of control slides were run in parallel to serve as an indicator 
of non-specific binding and antibody specificity. These controls, as 
mentioned in Materials and Methods, were of several d i stinct types. The 
first was the omission of e i t her the primary and/or the secondary antibody. 
As expected, deletion of either the primary or secondary antibody resulted 
in abolition of the staining. The replacement of the primary antibody by 
normal rabbit serum (NRS) of the same dilution resulted in a series of 
slides that could serve as indicators of non-specific binding. In the 
photornicrographs that follow, pictures of the control slides to which the 
NRS was added accompany the pictures of t he slides to which the primary 
antibody was added. 
The specificity of the anti-ACTH antibody was demonstrated by 
preabsorbing the antibody with SOng/ml ACTH for one and a half hours at 
room temperature. The slides to which t he preabsorbed antibody was added 
exhibited a level of staining similar to the NRS slides . A photomicrograph 
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of a preabsorbed anti-ACTH antibody can be seen in Figure 2.3b for the 
bovine PML. 
Two additional controls were run to further characterize the specificity 
of staining observed in the experiments. A negative control was run in 
which red blood cells of the bovine were subjected to the ICC protocol. 
Red blood cells are not known to produce ACTH or other POMC peptides; 
thus, as expected these cells were not stained by ICC. As an addit ional 
check on the specificity of staining, a positive control was run. For this 
control, the dispersed cells of the anterior pitui tary gland of a Harlem 
Sprague-Dawley rat were plated on the slide. Five to ten percent of the 
cells in the pituitary gland are reported to be corticotropes (Childs et 
al., 1989). Hence, it was expected that 5 to 10% of the dispersed cells 
would be stained after being subjected to the ICC . As seen in Figure 2.Sa, 
4% - 6% (duplicate slides) of the pituitary cells were stained by the ICC 
and thus, positive for ir-ACTH synthesis. 
As a final check on the specificity of the ICC protocol, the primary 
antibody was serially diluted. It was observed that as the concentration 
of the primary antibody was decreased, the intensity of staining also 
decreased. This pattern of staining was observed for each of the species 
probed for ACTH production. A clear example of this pattern was observed 
in a series of photomicrographs of the canine PML ( Figures 2.8-2.11). 
A summary of the results for each animal can be found under the 
appropriate animal heading. The quantitative assessments of the staining 
patterns observed for PML of each species are accompanied by representative 
photomicrographs . 
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Immunocytochemical detection of ACTH and met-enkephalin in bovine PML: 
The bovine PML stained positively for ir-ACTH (Figure 2.la) and ir-met-
enkephalin (Figure 2.2a). At a primary antibody dilution of 1:400 for the 
ACTH antibody and the met- e nkephalin antibody, 100% of the PML were 
observed to stain positively for ir-ACTH and ir-met-enkephalin. The amount 
of non-specific binding was negligible as evident in the respective control 
NRS photomicrographs (Figures 2.lb, 2.2b). 
Pre-absorption of the primary antibody with the ACTH antigen at a 
concentr ation of SOpg/ml effectively blocked staining of the bovine PML 
(Figure 2 . 3b). The level of staining observed for the preabsorbed antibody 
was comparable to the level of non-specific staining observed on the 
control NRS slide (Figur e 2 . 3c). 
Immunocytochemical detection of ACTH in rat PML and pituitary cells : 
The rat PML stained positively for ir-ACTH (Figure 2.4a). On each slide to 
which the ACTH antibody was added at a 1:400 dilution, 100% of the PML 
present were stained positively by the ICC. The slides to which 1:400 NRS 
was added were observed to show minimal staining (Figure 2.4b) . 
The dispersed pituitary cells were exposed to the primary a ntibody at a 
dilution of 1:1600. As seen in Figure 2.Sa, 4% - 6% (dupl icate slides) of 
the pituitary cells stained positively for ir-ACTH. Once again the 
addition of 1:1600 NRS in the place of the primary antibody was observed to 
abolish staining of the cells (Figure 2.Sb ). 
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Immunocytochemical detection of ACTH and &-endorphin in porcine PML: 
The porcine PML stained positively for ir-ACTH (Figure 2.6a) and ir-~ ­
endorphin (Figure 2.7a). At a primary antibody dilution of 1:400 for the 
ACTH antibody and 1:200 for the ~-endorphin antibody, it was clearly 
apparent that 100% of the porcine PML present were stained by the I CC. At 
the same respective concentration of NRS, the amount of staining observed 
was negligible (Figures 2.6b, 2.7b). 
Immunocytochemical detection of ACTH in canine PML: The canine PML 
stained positively for ir-ACTH ( Figures 2.8a, 2.9a, 2.lOa, and 2.lla). At 
a 1:400 dilution of the primary ACTH antibody, the canine PML were observed 
to be deeply stained (Figure 2.8a). As the primary antibody was further 
diluted the intensity of staining was observed to decline. At a 1:500 
dilution of the ACTH antibody, the staining of the PML was still quite 
pronounced in 100% of the cells present on the s lide (Figure 2 . 9a). When 
the ACTH antibody was further diluted to 1:800, t he PML were observed to 
display some degree of differential staining (Figure 2.lOa); however, 100% 
of the cells were still showing some degree of staining. Finally at a 
1:1000 dilution of the primary antibody, the proportion of cells staining 
positively for ir-ACTH dropped below 100% (Figure 2.lla). At each 
corresponding dilution of NRS, the degree of staining observed was 
negligible (Figures 2.8b, 2.9b, 2.lOb, and 2.llb). 
Figure 2.la: In the top photomicrograph bovine PML have been incubated 
with the ACTH antibody at a 1:400 dilution . Notice that 
100% of the cells shown have stained positively for ir-ACTH 
sys thesis 
Figure 2.lb : In the bottom photomicrograph bovine PML have been incubated 
with non-immune normal rabbit serum at a 1:400 dilution. 
The degree of staining exhibited by these cells was 
negligible when compared to the cells exposed to the anti -
ACTH antibody 
• 
4 • 
• 
• 
• 
• 
• 
• 
• • 
• 
• 
• • 
•• 
• 
• 
• 
• 
• 
• 
• • 
• • • 
.. 
• 
• 
• 
~
 .. 
• 
• 
• • 
• • 
• • • 
• • • 
• • 
• 
.: 
• 
• 
• 
•• 
.. • 
•• • 
• • 
. :.· . 
• ••• 
• 
• 
N
 
• 
• 
("') 
• • 
• • 
• 
• 
• •• 
• 
• 
•• 
• 
• • 
• • 
•• 
,, 
.. -
• 
• • 
•
•• 
• 
• 
• 
• 
• 
• 
• 
.. 
• • 
• 
• 
• 
• 
• 
•• 
• 
• 
• 
• 
•• 
• 
• 
• 
• 
Figure 2.2a: In the top photomicrograph bovine PML have been incubated 
with the anti-met-enkephalin antibody at a 1:400 dilution . 
Notice that 100% of the cells shown have stained positively 
for ir-met-enkephalin synthesis 
Figure 2 .2b: In the bottom photomicrograph bovine PML have been incubated 
with non-immune normal rabbit serum at a 1:400 dilution. 
The degree of staining exhibited by these cells was 
negligible when compared to t he cells exposed to the anti-
met-enkelphalin a ntibody 
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Figure 2 . 3a: In the top photomicrograph bovine PML have been incubated 
with the anti-ACTH antibody at a 1 :400 dilution. Notice 
t hat 100% of the porcine PML s hown have stained positively 
for ir-ACTH synthesis 
Figure 2 . 3b: In the bottom photomicrograph bovine PML have been i ncubated 
with the ant i -ACTH antibody at a 1:400 dilution. The anti-
ACTH antibody was preabsorbed with ACTH by incubating the 
dilute d antibody in a 50pg/ml ACTH solu t ion for ninety 
minutes at room t emperature . The degree of staining 
exhibited by t hese cel l s was negligible when compared to 
bovine PML incubated with the untreated anti-ACTH antibody 
at the same dilution 
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Figure 2 . 3c: In the photomicrograph on the right, bovine PML have been 
incubated with non-immune normal rabbit serum at a 1:400 
dilution. The degree of staining exhibited by these cells 
was negligible when compared to bovine PML incubated with 
the untreated anti-ACTH antibody at the same dilution 

Figure 2.4a: 
Figure 2.4b: 
In the top photomicrograph murine PML have been incubated 
with the anti-ACTH antibody at a 1:400 dilution. Notice 
that 100% of the cells shown have stained positively for ir-
ACTH synthesis 
In the bottom photomicrograph murine PML have been incubated 
with non-immune normal rabbit serum at a 1:400 dilution. 
The degree of staining exhibited by these cells was 
negligible when compared to the cells exposed to the anti-
ACTH antibody 
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Figure 2 .Sa: In the top photomicrograph murine pituitary cells have been 
incubated with the anti-ACTH antibody at a 1:1600 dilution. 
Notice that 4% - 6% (duplica te slides) of the dispersed 
pituitary cells shown have stained positively fo r ir-ACTH 
synthes is 
Figure 2 . Sb: In t h e bottom photomicrograph murine pituitary cells have 
been incubated with non-immune normal rabbit serum at a 
1:1600 dilution. The degree of staining exhibited by these 
cells was negligible when compared to t he stained 
cort i cotropes exposed t o t he anti-ACTH antibody 
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Figure 2.6a: In the top photomicrograph porcine PML have been incubated 
with the anti -ACTH antibody at a 1:400 dilution. Notice 
that 100% of the porcine PML shown have stained positively 
for ir-ACTH synthesis 
Figure 2 . 6b: In the bottom photomicrograph porcine PML have been incubated 
with non-immune normal rabbit serum at a 1:400 dilution. 
The degree of staining exhibited by these cells was 
negligible when compared to porcine PML exposed to the anti-
ACTH antibody at the same dilution 
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Figure 2.7a : In the top photomicrograph porcine PML have been incubated 
with the anti-~-endorphin antibody at a 1:200 dilution. 
Notice that 100% of the porcine PML shown have stained 
positively for ir-~ - endorphin synthesis 
Figure 2.7b: In the bottom photomicrograph porcine PML have been incubated 
with non-immune normal rabbit serum at a 1:200 dilution. 
The degree of staining exhibited by these cells was 
negligible when compared to porcine PML exposed to the anti-
~-endorphin antibody at the same dilution 
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Figure 2.8a: In the top photomicrograph canine PML have been incubated 
with the anti-ACTH antibody at a 1:400 dilution. Notice 
that 100% of the canine PML shown have stained positively 
for ir-ACTH synthesis 
Figure 2.8b: In the bottom photomicrograph canine PML have been incubated 
with non-immune normal rabbit serum at a 1:400 dilution. 
The degree of staining exhibited by these cells was 
negligible when compared to canine PML exposed to the anti -
ACTH antibody at t he same dilution 
' 
• 
• • 
• 
• " 
• 
• 
• 
' 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
" 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
•• 
• 
• 
• 
• 
• 
• 
• 
• 
• • 
• 
•• 
• 
G
 
• 
• 
• 
O
j 
$ 
• 
• 
• 
~
 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
,. 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
~
 
• 
• 
• 
• 
• 
• • 
• 
0 
• • 
• • 
• 
• 
• 
• 
• 
• 
• 
Figure 2.9a: In the top photomicrograph canine PML have been incubated 
with the anti-ACTH antibody at a 1:500 dilution. Notice 
that 100% of the PML shown have stained positively for ir-
ACTH synthesis. The intensity of staining was observed to 
be decreased below the level observed at the 1:400 dilution 
of the anti-ACTH antibody 
Figure 2.9b: In the bottom photomicrograph canine PML have been incubated 
with non-immune normal rabbit serum at a 1:500 dilution. 
The degree of staining exhibited by these cells was 
negligible when compared to the PML exposed to the anti-
ACTH antibody at the same concentration 
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Figure 2.lOa: In the top photomic rograph canine PML have been incubated 
with the anti-ACTH antibody at a 1: 800 dilut ion. The PML 
were observed to display some degree of differential 
staining at this antibody di lution; however, 100% of the 
canine PML shown stai ned positively for ir -ACTH synthesis 
Figure 2 .lOb: In the bottom photomi crograph canine PML have been incubated 
with non-immune normal r abbit serum at a 1:800 dilution. 
The degree of staining exhibited by these cells was 
negligible when compared to the PML exposed to the anti-
ACTH antibody at the same concentration 
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Figure 2 .lla: In the top photomicrograph canine PML have been incubated 
with the anti-ACTH antibody at a 1:1000 dilution. The PML 
were observed to display a large degree of differential 
staining at this antibody dilution. The percentage of PML 
stain positively for ir-ACTH synthesis has dropped below 
100%. It was apparent that percentages of cells observed to 
stain positively for ir-ACTH production could be modified by 
higher dilutions of t he primary antibody 
Figure 2.llb: In the bottom photomicrograph canine PML have been incubated 
with non-immune normal rabbit serum at a 1:1000 dilution. 
The degree of staining exhibited by these cells was 
negligible when compared to canine PML exposed to the anti-
ACTH antibody at t he same concentration 
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Western blot of the lysate from bovine p e riphera l mononuclear 
leukocytes: The lysate of t h e bovine PML was loaded into two lanes of a 
1S% po l yacrylamide gel. In another lane, cytochr ome c was loaded to serve 
as t he mo l ecula r weigh t marker; it h a s a kn own mass of 10 . S kDa . To 
char acterize t h e moveme n t o f ACTH in t h e gel, pur e samples of labeled I 125 -
ACTH a n d un labelle d ACTH wer e a l so loaded on the gel . 
Af ter r unni n g t h e l ysate on t he ge l , a d i stinct patter n of ban ds could 
ube ob served in the lanes into which t h e lysate was loaded . To determine 
if ACTH was present in the lysate, the gel was blotted and the blot was 
prob e d for ACTH using a n ACTH ant i body. After b lotting the gel, both it 
and the nitrocel l ulose memb r ane were placed on p r e - flashed Kodak X- ray film 
for ten days at - 70°C. 
Th e radioautograph s reveal ed that I 125 -ACTH mi grated to a position below 
that of cytochrome c; thus, as expected, t he SkDa ACTH migrated further in 
the gel than 10.SkDa cytoch rome c. Furthermore, I 125 - ACTH formed a broad 
diffuse band in the gel. It was not poss i ble to determine if ACTH was 
present in the lysate. No band corresponding to the position of ACTH could 
be seen in a lane i nto which the lysate was loaded. 
Neith er the p r esence nor the absence of ACTH i n the bovine PML lysate 
could be confirmed by the Western Blot. 
Discussion 
The results of the present study suggest that peripheral mononuclear 
leu kocytes (PML) from a broad spectrum of mammalian species synthesize pro -
opiomelanocortin (POMC) peptides. All PML examined by the avidin 
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biotinylated peroxidase complex (ABC) immunocytochemical method stained 
positively for presence of ir-ACTH. In addition to ir-ACTH, several other 
POMC peptides can be detected in PML. In particular, ir-~-endorphin was 
identified in porcine PML and ir-met-enkephalin was identified in bovine 
PML. These results partially agree with other reports on the synthesis of 
POMC peptides by the PML. 
Using an indirect immunofluorescence technique, 25% of the PML derived 
from humans with a ACTH deficiency were reported to stain positively for 
ir-ACTH. Six hours after administrating a typhoid vaccine, the percentage 
of the human PML stained positively for ir-ACTH increased to 50% (Meyer et 
al., 1987). 
A strain of mouse B-lymphocytes were observed to be 66% positive for ir-
ACTH (Bost et al., 1987). Once again an indirect immunofluorescence 
procedure was utilized. In contrast, in the current study, 100% of the P~fL 
isolated from the Harlem Sprague-Dawley rats were positively stained for 
ir-ACTH when t he ABC method was used. Clearly, the percentage of mouse P!11 
that stained positively for ir-ACTH (66%) was closer to the observed 
percentage of rat PML that stained positively for ir-ACTH (100%) than to 
t he percentage of human PML that stained positively for ir-ACTH (25%). 
Several different explanations account for t hese observed discrepancies. 
In the studies of Meyer et al. (1987) and Bost et al. (1987), a different 
type of indirect immunocytochemistry was utilized to probe for the presence 
of ir-ACTH; the secondary antibody was conjugated to fluorescein 
isothiocyanate. However, the ABC technique was used in the current study 
and it has been reported to be more sensitive than other indirect 
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immunocytochemical techniques (Hsu et al . , 198la , b). Thus, a reduction in 
technique sensitivity provides one explanation for the differences observed 
between the previous and the current studies. 
Species variation in ir-ACTH production may provide an alterative 
explanation for the observed differences in the number of PML staining 
positive for ir-ACTH. It is possible that the role ir-ACTH plays in a 
immune response may differ in the various mammalian species; however, it 
is clear that PML of mammalian species are capable of producing ir-ACTH . 
The Western blot was unable to confirm the irnrnunocy tochemical results 
obtained for the bovine PML; howeve r , the procedure was not fine tuned for 
the separation of ACTH from the s upernatant fluids of bovine PML lysates. 
In order to facilitate the detection of ir-ACTH by Western blot at l east 
two improvements will be required in the future. 
First, it will be necessary to selectively concentrate ir -ACTH from the 
lysates of PML before gel electrophoresis. One method to concentrate a 
protein of interest is irnrnunoprecipitation. Not only will the protein 
become more concentrated during the precipitation, it will a lso be 
partially purified by the specificity of t he precipitating antibody. 
Second, the lysate should be separated on a more suitable ge l matrix . 
The 15% polyacry lamide gel is best suited for t he separation of large 
molecular weight proteins; small proteins tend to form diffuse bands. The 
spreading of t he labelled ACTH into a diffuse band makes detection of the 
protein by Western blot difficult. If the lysate contains only a small 
amount of ir-ACTH , then spreading the protein over a large area (diffuse 
band) decreases the amount of protein , antibody, and I 125 -Prote in A bound 
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per unit area . Thus, the X-ray film may not receive adequate exposure to 
register the presence of a band and the protein may go undetected . 
The Western Blot offers considerable promise for the study of ir-ACTH 
synthesis by the PML. Once the system is fine tuned for the separation and 
detection of small proteins, it will be possible to simultaneously test the 
supernatant fluids of the lysates of PML cultures for multiple POMC 
peptides. The lysate supernatant solutions will y ield information on the 
contents of the cell. Cells can be subjected to different treatments , and 
the supernatants of the lysates can be assessed for the ability of a given 
treatment to induce the synthesis of POMC products. 
Even though the presence of ir-ACTH in the supernatant lysates obtained 
from bovine PML was not detected by the Western blot, another study 
provides indirect evidence of POMC peptide synthesis by bovine PML. Bovine 
PML infected with bovine herpesvirus-1 have been demonstrated to express 
the POMC gene (Westly and Splitter, 1987). It was unlikely that 
transcription of the gene for POMC would occur in bovine PML without the 
eventual translation of the rnRNA into peptide synthesis. 
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SECTION II. THE RELEASE OF ADRENOCORTICOTROPIC HORMONE (ACTH) BY BOVINE 
PERIPHERAL MONONUCLEAR LEUKOCYTES (PML) 
Introduction and Li t erature Review 
The f i rst par t of this study was concern ed with t h e s ucessful detection 
of stored immunor eactive -ACTH (ir-ACTH) and re l ated POMC pept i des by PML 
isol ated from a broad spectrum of mammalian s pecies. However, ICC provided 
no information on t h e r elease of POMC peptides from PML. In this section, 
the r elease of ir -ACTH by bovine PML was examined by radioimmunoassay 
(RIA) . 
The release of ACTH and POMC related peptides by PML has been reported . 
Human PML cultur ed with corticotropi n releasing factor (CRF) have been 
observed to release ir-ACTH and ir -~-endorphin into culture media (Smith et 
al., 1986) . The ir-ACTH molecule was observed to have a relative molecular 
weight of 4 .SkDa (the molecular weight of pituitary derived ACTH) and to 
exert a trophic action similar to that of ACTH on cultured mouse adrenal 
cells. 
Human B-lyrnphocytes have also been observed to release ~-endorphin in 
the absence of CRF . The release of ~-endorphin was dependent on t he 
presence of monocytes and was blocked by anti-interleukin 1 antibodies. 
Apparently the release of ~-endorphin by human B-lyrnphocytes was mediated 
by i nterleukin 1 ( I L-1). 
Besides human PML , only mouse B-lymphocytes have also been observed to 
release ir-ACTH (Bost et a l ., 1987). Culture media obtained from the 
cultures of mouse B-lymphocytes was purified on an affinity col umn. The 
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media eluted from the anti-ACTH (1 -13) affinity c olumn was observed to 
contain a peptide with a molecular weight and steroidogenic activity 
similar to pituitary derived ACTH. 
The release of POMC peptides by PML in other mammalian species has not 
been investigated. If the synthesis and secretion of POMC peptides by PML 
of mammalian species is a recurrent t heme, then it strengthens the v i ew 
that these peptides serve an immunoregulatory role. 
This part of the study concerns the release of ir-ACTH by bovine PML. 
An attemp t was made to identify potential secretagogues of ir - ACTH and t o 
measure levels of ir-ACTH released fr om bovine PML under basal and 
stimulated conditions. The cultur e media of treated and untreated bovine 
PML was assessed for ir - ACTH content using a radioimmunoassay. 
Materials and Methods 
Animals: Bovine blood was collected by venepuncture into a 250ml 
sterile screw top bottle containing 25ml of an Acid Citrate Dextr ose (ACD ) 
solution. The ACD solution was made by dissolving 132g sodium citra te, 58g 
citric acid , and lSOg dextrose into thrjee liters of reagent grade water. 
The PML cultured for each experiment wer e isolated from blood drawn that 
same morning. 
Leukocyte preparation: Whole blood collected by venepuncture into a 
250ml s terile screw top bottle containing lOml of ACD was divided evenly 
between four SOml centrifuge tubes and then spun on a Cent r a-8 centri fuge 
(International Equipment Company) at 850g for 22 minutes. Aft er 
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centrifugation, the samples were placed in a laminar flow hood. The huffy 
coat, the top of the plasma/cell interface, was drawn off along with Sml of 
plasma from each SOml tube and placed into a 15ml centrifuge tube. To each 
l Sml centrifuge tube was added Sml of a density gradient: Sepracell-MN 
(Sepratech Corporation). After adding the Sepracell-MN, each tube was 
capped, inverted several times and spun on the Centra-8 at 1900g for 22 
minutes. 
Following centrifugation with Sepracell-MN, a distinct white band was 
apparent just below the meniscus in each centrifuge tube. The white band 
containing PML was collected from each tube with a sterile Pasteur pipet 
and combined into a single lSml centrifuge tube whi ch was then filled to 
capacity with Hank's Balanced Salt Solution (Sigma ). The sample was 
triturated with a sterile Pasteur pipet , and spun on a Clinical centrifuge 
(International Equipment Company) at setting 6 for five minutes . Next, the 
supernatant fluid was decanted from the tube and Sml of Hank's medium was 
added again before the pellet was triturated with a sterile Pasteur pipet 
and filtere d through a sterile 25µm mesh into a clean 15ml centrifuge tube. 
The filtrate was t hen diluted to lOrnl , the tube was inverted several times , 
and an aliquot was taken for a cell count on a hemocytometer. 
The sampl e was then spun on the Clinical centrifuge at setting 6 for 
five minutes; the supernatant fluid was discarded and the pellet was 
diluted with leukocyte culture medium (LCM) to a concentration of 106 
cell/ml. LCM was made by adding lSrnl fetal calf serum (Gibco), lml 
penicillin-streptomycin (Gibco), and lrnl fungizone (Gibco) to lOOrnl of 
Media 199 (Gibco) . Next, lrnl of the leukocyte suspension was then 
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aliquoted to each well in a 24 well incubation tray (Corning Cell Wells , 
Corning Glass Works). The tray was then placed into a humidified Queue 
incubator set at 37°C, 5% C02/ 95% a i r, and the cells were allowed to 
incubate for 24 hours before t r eatmen ts were app l ied. 
Murine pituitary preparation : The anterior lobe of t h e pituitary was 
isolated from a f r eshly ki l led Harlem Sprague - Dawley rat and placed into a 
sterile siliconized petri dish (6cm diameter) containing a solution of 
Spinner's-0.1% bovine serum albumi n (BSA) which was made by adding l.lml 
penicillin- streptomycin (Gibco ) and 2.6rnl 4% BSA to lOOrnl of Spinner's 
Minimal Essential Medium (Gibco). The petri dish was placed in a laminar 
flow hood where the anterior lobe was transferred to a larger sterile petri 
dish (lOcm diameter), rinsed sever al times with fresh Spinner's-0.1% BSA, 
and cut into approximately lrnm3 p i eces with sterile scalpel blades. 
The pieces were next transferred to a siliconized spinner ' s flask 
containing lOml of a lmg/ml t r ypsin solution in Spinner's -0.1% BSA that was 
filtered t h rough a Millex- GV fi l ter. The flask was gassed through a 
sidearm for twenty seconds with 5% C02/ 95% air, placed in a 37°C water 
bath, and left to incubate with stirring for 50 minutes . After stirring, 
the solution was triturated unde r the laminar flow hood using a sterile 
Pasteur pipet, regassed through the sidearm, and left to incubate for 
another 30 minutes. This procedure was repeated at 20 minutes intervals 
until the pieces of the anterior pituitary were no longer visible. 
After dispersing the pituitary cells, they were transferred to a 15ml 
centrifuge tube, made up to 15ml with Spinner's and spun on a Clinical 
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centrifuge (IEC) at setting 5 for 10 minutes. The supernatant fluid was 
decanted, 5ml Spinner's was added to the pellet which was triturated with a 
Pasteur pipet . An aliquot was removed for a cell count in a hemocytometer, 
then the suspension of pituitary cells was diluted to 15ml with Spinner's 
and spun on a Clinical centrifuge at setting 5 for 10 minutes. 
The pellet was resuspended in leukocyte culture media (LCM) to achieve 
the concentration of pituitary cells desired for the experiment. The 
pituitary cells were dispensed in lml aliquots to each of the wells in a 24 
well culture tray (Corning Cell Wells, Corning Glass Works). The tray was 
then placed inside a humidified Queue incubator set at 37°C, 5% C02/ 95% 
air, and left to incubate for 24 hours before the treatments were applied. 
Cell culture treatments: Treatments were applied in an identical manner 
in each experiment and on each type of cell culture. After incubating in 
the Queue incubator for 24 hours, the 24 well culture trays containing the 
cultured cells were removed from the incubator and placed in the laminar 
flow hood. Next , 250µ1 of culture media was removed from each well with a 
sterile pipet and replaced with 250µ1 of fresh media containing the 
appropriate treatment. The cells were allowed to incubate with the 
treatments in a humidified Queue incubator at 37°C for 6 hours . 
After six hours, aliquots of culture media were then taken from each 
well, placed into vials, and frozen at -20°C until assayed for ACTH by 
radioimmunoassay (RIA). 
The following is a listing of the treatments applied to the leukocytes: 
(1) leukocy te culture media (LCM; control), (2) lOOng/ ml ACTH (porcine) , 
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( 3) 6.5 µg/ ml Concanavalin A (ConA), (4) 50nM corticotropin releasing 
factor (CRF), (5) 6.5 µg/ml ConA and 50nM CRF , (6) lOnM and l OO nM phorbol-
12-myristate-13-acetate (PMA), (7) 1 µMand 5 µM calcium ionophore, A23187, 
and (8) 1:80 and 1:10, 000 dimethyl sulfoxide to LCM (dimethyl sulfoxide was 
the vehicle of PMA and A23187). 
The pituitary cells were treated with either LCM (control ) or 50nM CRF. 
Radio immunoa s s ay (RIA): The procedure followed was provided by the IgG 
Corporation (P.O . Box 120052, Nashville , Tennessee, 37 212-0052) with some 
slight modifications. On the first day of the procedure, the samples to be 
assayed were melted on ice along with the ACTH standard (IgG -pACTH, IgG 
Corporation ) and the ACTH antibody (IgG -ACTH -1 , IgG Corporation ) . While 
the samples were melting, the RIA buffer was freshly mixed from an ice cold 
pho sphate ethylenediaminetetraacetic acid (EDTA) buffer (8.94g/ l sodium 
phosphate dibasic , 4. 74g/ l disodium EDTA dihydrous, and 0.2g/ l sodium 
azide) by adding lµl Triton X-100 and 250 KIU aprot inin (Sigma) per ml of 
buffe r. 
ACTH has been observed to be a ve r y labile protein. Hence, t he RIA was 
performed at 4°C to limit the extent of protein degradation. Several 
additional steps were taken to minimize the degradation of ir -ACTH in t he 
system. Triton X-100 was added to limit t he extent of non- s pecific binding 
of t he i r -ACTH to the polypropylene tubes. Aprotinin , a protease 
inhibitor , was adde d to i nhibit ir-ACTH degradation by pro teases in the 
system. 
After the samples were melted, the standards were prepared by tak ing 100 
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µl of standard ACTH concentrate (lng/µl) and adding to 9.9ml of RIA buffer 
in a tube labelled 'A'. After vortexing, 100µ1 of solution A was added to 
4.9ml of LCM in a tube labelled 'B', thereby obtaining a standard solution 
of 200pg/ ml ACTH. The remaining standards (lOOpg/ml, SOpg/ml, 25pg/ml, 
12.Spg/ml, 6.25pg/ml, and 3.125pg/ml) were made by double dilutions. 
The entire procedure was carried out at 4°C with all reagents chilled on 
ice or in a refrigerator. On the first day, 100µ1 of antibody (1:100 
dilution of stock antibody to RIA buffer) and 100µ1 of either standard or 
sample were added to numbered 12 x 75mm polypropylene tubes . The tubes 
were then vortexed and placed in a rack on ice. The racks were covered 
with plastic wrap, moved to a refrigerator at 4°C , and left to incubate for 
24 hours. 
In a single assay, each standard was replicated three times; each media 
sampl e was replicated twice . In addition, a series of standards (lOOpg/ml, 
25pg/ml, and Spg/ml) were mixed and frozen fo r subsequent experiments. 
These standards were used to measure intra-assay and inter-assay 
coefficients of variation. 
On the second day, after the antibody and sample had incubated at 4°C 
for 24 hours, the racks were repacked in ice and moved back to the lab. 
Next, 100µ1 of a 20,000 cpm/ml solution of 1125 ACTH (Amersham) in RIA 
buffer was added to each tube. After vortexing, the tube was returned to 
the rack, covered with plastic wrap and moved into a refrigerator at 4°C 
for an additional 24 hours of incubation. 
On the third day, the racks containing the samples were repacked in ice 
and moved into the lab where 100µ1 of 1:40 normal rabbit serum (Calbiochem) 
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in RIA buffer and 100µ1 of anti-rabbit-immunoglobulin antibody 
(lunit/100µ1, Calbiochem) were added to the tubes. The tubes were then 
vortexed, covered with plastic, a nd moved into a refrigerator at 4°C for 4 
hours of incubation. After 4 hours, l.Sml of ice cold 6% polyethylene 
glycol in 0.9% NaCl was added to each tube. The tubes were then 
transferred to centrifuge tube holders and spun on a Beckman centrifuge 
(Model J-6B) at 4°C, 1900g for one hour. After centrifugation, the tubes 
were placed in an ice bath and individually decanted by slowly inverting 
the tube while removing the supernatant with a syringe attached to a vacuum 
source. Finally, the tubes were loaded on a gamma counter (Compugamma 
Gamma Counter, LKD Instruments, Inc.), counted, and then discarded. 
The standard curve was computed on a Hewlett-Packard 41C calcul ator 
using the Clinical Lab and Nuclear Medicine Pac. In brief, the program 
performs the calculations for a logit/log plot of the data. After input of 
the standard data, the program computes a slope, a correlation coefficient, 
an intercept, and the least-squares regression line for the standards. 
Next, the cpm obtained for the media samples was input to determine if ir-
ACTH was secreted into the media by the cell culture. The data was 
reported in terms of picograms of ACTH detected per ml of media. 
ACTH degradation : To study the degradation of ACTH in culture 
conditions, a sterile solution of lOOpg/ ml ACTH in leukocyte culture media 
( LCM ) was prepared in a laminar flow hood and then dispensed in lml 
aliquots to each well in a 24 well culture tray (Corning Cell Wells , 
Corning Glass Works). The tray was next transferred to a humidified Queue 
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incubator set at 37°C, 5% C02/ 95% air, then left to i n cubate. Two-
hundred an d fifty µl aliquots of the culture media were taken from a 
different set of four wells at 4, 6, 12, 24, 48, and 78 hours . Each 
a liquot was placed in a vial, capped, and transferred to a freezer at 
20°C. The samples were later assayed for ir-ACTH by RIA. 
Re sults 
Assay v a l i dat ion : The radi oimmunoassay (RIA) utilized in the following 
series of experiments was modified from a procedure supplied by the IgG 
Corporation. The assay characteristics listed be l ow were based on the data 
obtained from 11 separate assays. These observed characteristics agreed 
well with those supplied by the manufacturer of the RIA. 
The trace binding was observed to average 39.7% ± 2 . 2% (x ± SEM, n=ll). 
This binding refers to the percentage of labelled ACTH that was bound by 
the ACTH antibody under assay conditions and was obtained from the cpm 
bound in polypropylene tubes to which only media (LCM), labelled ACTH, a nd 
the ACTH antibody were added. To achieve maximum sensitivity for the 
detection of ACTH, IgG Corporation recommended that 30-35% of the total cpm 
added per tube should be bound. 
The sensitivity was 11.lpg/ml ± l.8pg/ml (x ± SEM, n=ll). This amount 
of ACTH was required to reduce B0 by 10%. The 50% binding range was 
42 . 6pg/ml ± 5 . 19pg/ml (x ± SEM, n=ll). The upper limit of the assay, when 
the sample count was reduced to 20% of B0 , was 100.0pg/ml ± 10.6pg/ml (x ± 
SEM, n=l l ). 
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The degree of variation observed between the 11 experiments was within 
acceptable limits. The inter-assay coefficient of variation was determined 
for three separate stock solutions of ACTH (lOOpg/ml, 25pg/ml, and 5pg/ml). 
The coefficients of variation were 8.9%, 18.3%, and 19.5%, respectively. 
The intra - assay coefficient of variation was measured in a single assay 
on a standard solution of 25pg/ml and was determined to be 8.8% (n-10). 
The cross reactivity of the antibody used in these experiments was 
tested, the following information was provided by the IgG Corporation: 
ACTH(l-39), 100%; ACTH(l-24), 170%; ACTH( l-18 NH2), 170%; ACTH(l-16 
NH2 ), 0.4%; ACTH(5-24), 128%; ACTH(7-24), 151%; ACTH(9-24), 11%; 
ACTH(ll-24), 0 . 1%; ACTH(l3-24), <0.1%; ACTH( l 5-24), <0. 1 %; ACTH(l7-24), 
<0.1%; ACTH(l8-39), <0.2%; ACTH(5-18), 101%; oMSH, <0 .2%; human-~MSH, 
<0 . 4%; human-~ - endorphin, <0.5%; human-~LPH, <l.3%; human-LPH, <0.8% . 
ACTH degradation: ACTH was observed to be rapidly degraded under 
culture conditions . Upon subjecting a solution of lOOpg/ml ACTH in LCM to 
cell-free cul tur e conditions, ACTH was observed to have a half life of 
approximately 8 hours. The temporal pattern of degradation was determined 
by taking samples of the spiked media at discrete times. The media samples 
were later quantitated for ACTH content using RIA. The results on the 
degradation of ACTH have been displayed in Figure 3.1. After 48 hours of 
incubation at 37°C, the amount of ACTH that could be detected in the spiked 
media h ad approached the sens itivi ty of the RIA (11.l pg/ml, see above). 
Figure 3 .1: The degradation of ACTH under culture conditions. ACTH had a 
half life of approximately 8 hours when incubated in cell fr ee 
leukocyte culture media (LCM) placed in a humidified Queue 
incubator at 37°C, 5% C02/ 95% air. The valves were reported 
as the mean ± the standard deviation (n=4) 
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ACTH r eleas e by rat pitu itary cells: Rat pituitary cells cultured 
under the same conditions as the bovine PML were observed to release ir-
ACTH into t he cultur e media. As the concentration of pituitary cells per 
ml LCM was increased, a concomitant increase in ir-ACTH release was 
observed ( Figure 3.2). The addition of a solution of SOnM corticotropin 
releasing factor (CRF) to the LCM was observed to increase the a.mount of 
ir-ACTH released. CRF stimulated pituitary cells released significantly 
more (P > t - 0.05 or less ) ir-ACTH than non-stimulated pituitary cells 
cultured under the same conditions and at the same cellular concentrations 
( Figure 3 . 2) . 
ACTH re l e a se by bov i n e PML: To detect the basal release of ir-ACTH by 
bovine PML, they were cultured at a concentration range of 104 to 106 cells 
per ml of LCM. Media samples from the cultured bovine PML were taken afte r 
24 , 48, and 7 2 hours of incubation ; howeve r , no basal release of ir-ACTH 
was detected. Higher cell concentrations were not quantitated for ir-ACTH 
r e l e ase b ecause the PML were observed to agglutinate. The agglutination of 
bovine PML prevented the uniform distribution of these cells within the LCM 
a nd hence to t he culture wells . 
To minimize the degradation of the released ir-ACTH in treated bovine 
PML cultures , media samples were taken 6 hours after the treatments were 
applied t o the cultures ( see Materials and Methods : Cell culture 
treatments). Treatment of the bovine PML with two putative secretagogues, 
CRF and ConA , was not observe d to stimulate the release of ir-ACTH from the 
cells. Treatment of bovine PML with pharmacologic al agents (PMA and 
Figure 3.2: The release of ir -ACTH by dispersed pituitary cells under 
culture conditions. After 24 hours of incubation in a 
humidified Queue incubator at 37°C, 5% C02/ 95% air, media 
samples were quantitated for ir-ACTH content by RIA. As the 
cell concentration was increased, the amount of ir-ACTH 
released into the media increased. Treatment of the pituitary 
cells with corticotropic releasing hormone (CRF) resulted in a 
significant rise in the levels of ir-ACTH released into the 
media . All bar s marked with a different letter are 
significantly different at the 5% level ( P > t- 0.05 or less) . 
Values were reported as the mean ± the standard deviation 
(n-4) 
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A23187) was also not observed to stimulate t he r e lease of measurable 
amounts of ir -ACTH into the culture media. 
Discussion 
The RIA procedure was validated in the course of this study. The assay 
characteristics have been summarized above (see Results section). In 
brief, the RIA was capable of detecting ir-ACTH at the 11.lpg/ml level. 
The RIA was capable of detecting the release of ir-ACTH under the employed 
culture conditions as demonstrated by the release of ir-ACTH from rat 
pituitary cells. Furthermore, it was possible to stimulate release of ir-
ACTH from the pituitary cells by app l ying a known corticotropin 
secretagogue , CRF. 
The inability to detect the release of ir-ACTH by bovi ne PML in the 
present study is at odds with t he observations of its release from human 
(Smith et al., 1986) and mouse PML (Bost et al., 1987). This discrepancy 
has several explanations. (1) The amount o f ir-ACTH released from bovine 
PML was insufficient for detecti on by the RIA protocol used in this study. 
(2) The released ir-ACTH was degraded before it could be detected. (3) The 
bovine PML were not stimulated to release ir-ACTH into the culture media or 
(4) t h e cows that served as donors of the PML were stressed or otherwise 
perturbed by outside influences. Each of t h ese explanations will be 
discussed below. 
( 1 ) The amount of ir-ACTH secreted by human PML is minute. To detect 
the presence of ir-ACTH by radioimemunoassay, 2 x 107 human PML were l ysed 
in 2ml of O.O lM HCl before the lysate was conce ntrated and quantitated. A 
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median value of 29pg of ir-ACTH was observed (Buzzetti et al., 1989) . If 
bovine PML synthesize a similar amount of ir-ACTH, then even the complete 
release of all the ir-ACTH produced by all 106 bovine PML in a single 
culture well was below the sen sitivity of t h e RIA used in the curren t 
study. 
To detect the release of ir-ACTH, the media of cultured mouse B-
lymphocytes was passed through an immunoaffinity column conjugated with 
anti-ACTH antibody . Several of the e luted fractions were observed to a 
contain a steroidogenic material (Bost et al., 1987 ). The eluted fraction 
which induced the l argest increase in corticosterone production by an 
adrenal cell lines corresponded with the SkDa fraction. Recall that ACTH 
has a molecular mass of about SkDa. The eluted fractions we r e further 
characterized for the presence of ir-ACTH by RIA. It was found that 43ml 
media eluted from the affinity column contained an average of 875pg of an 
ir-ACTH molecule (43ml of media contained 4.5 x 107 cells ). 
In order to detect the presence of ir-ACTH in the supernatant f l uids of 
the mouse B lymphocytes, it was necessary to selectively concentrate t h e 
molecules of interest on an affinity column. The supernatant fluids of the 
bovine PML were not subjected to any type of purification before being 
assayed by t he RIA. If the bovine PML secreted amounts of ir-ACTH 
comparable to that observed for human PML and mouse B lymphocytes, the 
levels secreted were at least ten fo ld below the sensitivity of the RIA. 
(2) ACTH was degraded rapidly in culture conditions. It was observed to 
have a half life of 8 hours under cell free culture conditions. The media 
samples quantitated by RIA in the current experiments were taken 6 hours 
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after treatmen ts were applied. Clearly, if ir-ACTH was released by bovine 
PML a f ter treatment, it was subject to prompt degradation. 
(3) The release of ir-ACTH by bovine PML may not have b een t riggered. 
The regulatory signals that control t h e release of ir-ACTH and other POMC 
peptides from bovine PML have not been identified. It was hoped that the 
pharmacological agents ( PMA and A23187) would e lici t a release of 
cytopl asmic granules contained in the bovine PML. Several mitogenic agents 
were also utilized t hat have been shown to induce the synthesis and/o r 
release of POMC p e ptides from the PML of humans a n d mice (Besedovsky el al, 
1981 ; Smi th et a l ., 1986). However, none of the treatments were observed 
t o induce the release of detectable a mounts of ir-ACTH from bovine PML . 
(4) The donors f rom which PML were isolated may have been suffering from 
sub-clinical infec t ion. Many of the animals were housed communally; thus, 
t h e possibility existed fo r the horizontal transmission of disease between 
the individual donor animals. 
This pre-expos ure to pathogens may affect the ability of PML to 
synthesize and release cytokines. To test this hypothesis, cul ture PML 
isolated from the blood of a pathogen free anima l to the RIA p r otocal and 
assay fo r ir-ACTH. 
Summary: the ability of bovine PML to r e l ease ir-ACTH could not be 
c onfirme d . Proof of r e l ease awaits the e mployment of increasing sensi tive 
assays and/ or methods of se l ectively concen trating the proteins of 
interest . One possible candidate is the Western blo t which should prove 
useful in the characterization of PML ab ili ty to synthes i ze and release the 
various POMC peptides . 
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GENERAL DISCUSSION 
The present study shows that the synthesis of ir-ACTH by PML occurs in a 
broad spectrum of mammalian species: cow, pig, dog, and rat; however, the 
release of ir-ACTH by PML has only been characterized in humans and mice 
( Harbour-McMena.min et al., 1985; Bost et al., 1987; Meyer et al., 1987 ) . 
Several other peptides of proopiomelanocortin (POMC) origin have also been 
identified in PML. In particular, ir-fi-endorphin has been observed in pigs 
(current study), in humans (Harbour-McMena.min et al . , 1985; Smith et al. 
1986; and Kavelaars et al., 1989) and in mice (Lolait et al., 1984). 
Immunoreactive met-enkephalin has been identified in cattle (current 
study). Expression of the gene for POMC has also been reported in bovine 
PML infected with bovine herpesvirus-1 (Westly and Splitter, 1987). It is 
apparent that PML isolated from mammalian species are capable of expressing 
and releasing POMC related peptides. 
The release of ir-ACTH by bovine PML was not detected in the current 
study. However, as mentioned before (see Discussion in SECTION II), the 
release of ir-ACTH by human PML and mouse B-lymphocytes was determined to 
be on the order of 10-60 pg per 107 cells. Bovine PML were cultured at 106 
cells/ml in the current study. If bovine PML were to release ir -ACTH at a 
level similar to mice or humans, then only l-6pg would be released by 106 
cells. These concentrations of ir-ACTH were below the limits of the RIA to 
detect (sensitivity was 11.lpg/ml ACTH). 
The observation of POMC synthesis and release by PML does not address 
the function these peptides play in controlling the development of an 
immune response. If POMC peptides are capable of directly modulating the 
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functions of the PML during antige nic stimulation, then PML must possess 
specific receptors for POMC peptides . Several studies have demonstrated 
the existence of POMC receptors on the surface of PML. 
The presence of morphine and met-enkephalin receptors on t he s urface of 
human T-lymphocytes was reported when these two peptides were observed to 
suppress and enhance, respectively, the formation of sheep red blood cell 
rosettes (Wybran et al. , 1979) . Incuba t ion of the T-lymphocytes with 
morphine a t a concentration of 10-10 M to 10-7 M for one hour was observed 
to suppress the number of rosettes formed by the T-lymphocytes. Incubation 
of the T-lymphocytes with met-enkelphin ( 10- 7 M to 10-4 M) increased the 
number of r osettes formed . 
~-endorphin receptors have also been reported on human PML. 1 125 -D -
Ala- end orphin was observed to bind s pecifically to cultured human PML 
(Hazum et al., 1979). The binding o f the labelled endorphin was partially 
inhibited by human ~-endorphin at a concentrat ion of 10-9 M and complete l y 
inhibited at 10- 5 M. Additional opia te receptors have been observed on 
murine ( mouse) s pleenocytes (Carr e t al., 1989). 
Finally, t h e presence of ACTH receptors on human PML has been reported 
(Smith et a l. , 1987). These receptors were shown to be simila r in number 
and a ffinity to adrenal cel l ACTH receptors. 
Given that PML possess receptors for POMC peptides, t hen i t i s 
reasonable to assume that POMC peptides are cap able of directly affecting 
activities of PML . A number of POMC peptides have been observed to affect 
t he activation , proliferation, and ac t ivities of PML and oth e r 
immunocompetent cells. A summary of t h e act ions of POMC peptides follows. 
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ACTH and a-endorphin can inhibit the release of antibodies by mouse B-
lymphocytes (Johnson et al., 1982) when applied at 0.5 µM concentration. 
ACTH has also been implicated in repressing the release of ~-interferon 
from mouse spleen cells. When the mouse spleen cells were exposed to 
concentrations of ACTH in the range of 1 to 3µM, the spleen cells released 
less ir-~-interferon than those cells cultured in media alone (Johnson et 
al., 1984). ~-interferon concentration was assessed by neutralization with 
a specific antiserum. Later, it was determined that ACTH blocked the 
capacity of ~-interferon to activate mouse peritoneal macrophages to 
cytotoxic state (Koff and Dunegan, 1985). The concentration required to 
block the activation by ~-interferon was 0.5-lµM ACTH. Whether ACTH 
directly or indirectly blocked the release or the action of ~ - interferon 
remains uncertain; however, ACTH apparently can suppress the activation of 
macrophages by ~-interferon. 
fi-endorphin and met-enkephalin , on the otherhand, have been observed to 
enhance the release of ~-interferon by ConA stimulated human PML (Brown and 
Van Epps, 1986) . The release of ~-interferon as measured by indirect 
enzyme-linked immunosorbent assay was enhanced when fi-endorphin was present 
in concentrations ranging from 10-14 M to 10-10 M or when met-enkephalin was 
present in concentrations ranging from 10-13 M to 10-11 M. At higher 
concentrations, the release of ~-interferon was not augmented by either 
peptide. 
fi-endorphin has also been observed to enhance or suppress the 
proliferation of lymphocytes depending on the timing of the 
administration. Rat s pleen cells cultured in the presence of ConA and ~ -
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endorphin incorporated more labelled thymidine than those cultured with 
ConA alone. The effect was apparent at a concentration of lng/ml fi-
endorphin (Gi lman et al., 1982). 
On the other hand, human lymphocyte proliferation was observed to be 
repressed by the addition of fi-endorphin to the cultures (McCain et al . , 
1982) . The human lymphocytes were cultured with phytohemagglutinin, a T-
lymphocyte mitogen, in the presence and absence of fi-endorphin. At 
nanomolar concentration, fi-endorph i n was observed to repress the uptake of 
labelled nucleic acids; however, the suppression was evident only if fi-
endorphin was applied at the same time as the mitogenic stimulus. 
Finally, both fi-endorphin (10-14 M) and met-enkephalin (10-9 M) are found 
to enhance the cytotoxicity of human natural killer cells. The enhanced 
cytotoxicity was measured by the release of Cr51 from target cells (Mathews 
et al., 1983; Fa ith et al., 1984; Froelich and Bankhurst, 1984; Kay et al., 
1984; and Mandler et al., 1986). 
Thus, it is apparent that PML are capable of synthesizing, releasing, 
and interacting with POMC related peptides; however, are these actions of 
the POMC peptides of phys iological importance or are the observed 
activities of POMC peptides merely an artifact of the experiment 
conditions? To address t his question, one must consider the environment 
were a immune response is initiated . 
Acquired immunity is mediated and ini tiated by lymphocytes in the 
secondary lymphoid organs- the spleen and the lymph nodes. The lymph node 
contains numerous cells types s upported by meshwork of sinusoidal fibers in 
a tough collagen capsule. Lymphocytes are concentrated in the cortical and 
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paracortical regions of a node, while macrophages are found in the 
medullary regions. The cells are present in high concentrations; thus, 
intimate contact occurs between immune cells . Two basic types of 
interactions occur at a local level: cell to cell contact, and the release 
of cytokines. The anatomy of a node ensures that the cytokines, even 
though released in minute quantities, are effective in playing their 
respective roles in the control of a immune response. The autocrine and 
paracrine routes of the released cytokines are favored within a lymph node. 
The POMC peptides released by PML may exert actions beyond the local 
environment. The level of action being dependent on the strength of the 
stimulating signal. With mild stimulation, POMC peptides act at the l ocal 
level within the lymph node. Under extreme stimulation, POMC peptides may 
reach sufficient concentration to affect systemic function. 
Several systemic effects of cytokines have been noted. In sudden acute 
infections, the cytokines reach a sufficient concentration to exert 
systemic action. Hypophysectomized mice infected with Newcastle's disease 
virus have been observed to display a time -dependent increase in 
corticosterone plasma levels. The increase was attributed to the release 
of a corticotropic peptide by viral stimulated lymphocytes ( Smith et al . , 
1982). IL-1 has been implicated in the release of ACTH from the anterior 
pituitary (Fukata et al . , 1989) and the induction of fever (Widman, F.K., 
1989). 
Considering the local release POMC peptides by PML , it is probable that 
the ir-POMC peptides identified in the PML function as cytokines. ACTH, ~­
endorphin, and other POMC peptides have been shown to affect the activities 
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of PML. The presence of ir-ACTH, ir-~-endorphin, and ir-met-enkephalin in 
PML of several mammalian species has been demonstrated. In the current 
study the presence of ir-ACTH in PML of cows, pigs, dogs, and rats was 
found. Finally, the presence of specific receptors for POMC peptides has 
been detected. Given this information, it is reasonable to assume that ir-
POMC peptides produced by PML are partially responsible for controlling the 
course of a immune response. 
At the present, the signals that fine tune an immune response against 
the stimulating antigenic material are incompletely defined. There would 
be obvious advantages to understanding the pathways that influence the 
various cell types involved in the immune response. 
As an example, consider an infectious disease of felines that suppresses 
the immune system: feline leukemia virus (FeLV). FeLV suppresses the 
ability of helper T-lymphocytes to release stimulating cytokines and of B-
lymphocytes to release of IgG antibodies (Rojko and Olsen, 1984; Ogilvie et 
al., 1988). Felines with a persistent FeLV infection may develop secondary 
infections, which are often fatal due to imrnunosuppression. If the 
regulatory signals released by helper T-lymphocytes could be supplied 
exogenously , then the effects of FeLV could be bypassed and immune function 
could be restored. Some felines demonstrate improved clinical signs and 
clearance of viremia when heterologous interferons are included with 
antibiotics in the FeLV therapy (Weiss, 1988) . Additional cytokines have 
yet to be tested for their efficacy in terminating the FeLV infection. 
However , before any logical approach can be taken to the administration of 
cytokines for immunomodulatory effects, it will be necessary to identify 
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the structure, action, and sour ce of the cytokine. One set of proteins 
that may function as cytokines are the POMC peptides released by PML. 
In summary, it is possible that the ir-POMC peptides identified by the 
current study serve an important regulatory role in the immune response. 
The PML of cows, pigs , rats, and dogs stained positively for ir-ACTH. 
Furthermore, human and mouse PML have been observed to synthesize, release, 
and response to POMC peptides. Given this information , it is reasonable to 
hypothesiz e that POMC peptides synthesized and released by mammalian PML 
a r e cytokines that function in controlling immune responses. 
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